HIRIP3 emerges as a novel therapeutic target, and understanding its contribution to these diseases could unveil shared molecular pathways, thereby facilitating the development of targeted therapies to mitigate the risks associated with diabetes and its complications. This evidence concerns the gene HIRIP3 and diabetes mellitus.